
The biggest PBMs are handling more and more of the country’s drug price negotiations
The PBM industry has only grown despite its motto of lowering drug costs, and concerns remain about PBMs' incentives and contract terms.
Read The StoryExploring the intersection of finance, pharma, and biotech
The PBM industry has only grown despite its motto of lowering drug costs, and concerns remain about PBMs' incentives and contract terms.
Read The Story